#USA #Innovation #oncology #Amgen #Thousand Oaks

Amgen to Present at Citi's 2025 Virtual Oncology Leadership Summit

On February 19, 2025, Amgen (NASDAQ: AMGN) will make a significant appearance at Citi's 2025 Virtual Oncology Leadership Summit. This event is scheduled to begin at 3:00 p.m. ET and is expected to connect healthcare professionals, investors, and media representatives alike. Leading the discussion will be Jean-Charles Soria, Senior Vice President of Oncology at Amgen. This presentation underscores Amgen's role in the evolving landscape of oncology and its commitment to advancing treatment options for patients battling cancer.

The summit will be accessible via a live webcast that can be streamed online. This format allows a wide audience, including journalists, investors, and the general public, to partake in the event. The archived version of the presentation will also be available for replay on Amgen's website, ensuring that those unable to view it live can still access this critical content within at least a 90-day timeframe following the event.

What to Expect from Amgen

Amgen is renowned for its dedication to discovering, developing, manufacturing, and delivering innovative medicines. For over four decades, the company has played a pivotal role in establishing the biotechnology industry, consistently pushing the boundaries of medical science. The upcoming presentation at the summit aims to highlight not only Amgen's current advancements but also its ongoing commitment to a robust pipeline targeting cancers, heart disease, osteoporosis, inflammatory diseases, and various rare diseases.

The company's focus on innovation in oncology reflects its broader strategy of leveraging technology alongside insights derived from human genetics. This approach has positioned Amgen at the forefront of scientific discovery and development in the pharmaceutical sector.

Additionally, Amgen has been recognized for its innovative endeavors, claiming titles such as one of the “World's Most Innovative Companies” by Fast Company and being listed among “America's Best Large Employers” by Forbes in 2024. It is noteworthy that Amgen is part of the formidable Dow Jones Industrial Average and the Nasdaq-100 Index, showcasing its significance and influence in the market.

Staying Connected

Amgen aims to foster relationships within the healthcare community. Following the summit, ongoing updates and insights about its pipelines and developments will be promoted through various channels. Interested parties can follow Amgen on their social media platforms, including X (formerly Twitter), LinkedIn, Instagram, YouTube, and Threads, to stay informed.

The anticipation leading up to the 2025 Virtual Oncology Leadership Summit reflects a momentous period for Amgen as it continues to innovate and provide solutions tailored to the needs of patients around the globe. By participating in such prominent discussions, the company takes another step toward fulfilling its mission of delivering high-quality care through innovative therapeutic solutions.

For more detailed information and updates, please visit Amgen's official page where event details, webcast links, and additional corporate news are regularly posted.

Conclusion

As Amgen prepares for its presentation at Citi’s Oncology Summit, all eyes will be on its latest research and updates. The company’s pioneering spirit and commitment to patients position it as a leader in biopharmaceutical innovation, making this summit not just a presentation but a significant milestone for cancer treatment advancements. Don't miss out on this opportunity to witness unparalleled expertise and dedication in oncology science.